Document is current
Any future updates will be listed below
-
Authors
Scheen, André J. https://orcid.org/0000-0001-9743-4371
- License Information
-
More Information
Article History
Accepted: 25 August 2024
First Online: 28 September 2024
Declarations
:
: No sources of funding were used to assist in the preparation of this manuscript.
: André J. Scheen has no conflicts of interest to declare that may be relevant to the contents of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: André J. Scheen as the only author.
: André J. Scheen has received lecturer/scientific advisor/clinical investigator fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, and NovoNordisk, and has worked as a clinical investigator in the EMPA-REG OUTCOME, CANVAS-R, DECLARE-TIMI 58, LEADER and HARMONY Outcomes cardiovascular outcome trials.
